Speaker Interviews

Blood-Brain Barrier-Crossing Single-Domain Antibodies Targeting IGF1R: Mechanism of Action and Preclinical Assessment

Danica Stanimirovic, MD, PhD, Director, Translational Bioscience Department, Human Health Therapeutics Portfolio, National Research Council of Canada

View the Interview

April 2, 2019 Clinical Research News
Digitization Promises Improved Outcomes In Clinical Research Space